Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

285 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Recruiting

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

NCT05022459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University Palo Alto, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View Trial Details
Recruiting

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

NCT06940830

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Zagreb, Croatia
  • Sobi Investigational Site Brno, Czechia
  • Sobi Investigational Site Ostrava, Czechia
  • Sobi Investigational Site Prague, Czechia
View all 29 locations
View Trial Details
Recruiting

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

NCT07644832

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Xiangya Hospital of Central South University Changsha, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jinan Central Hospital Jinan, China
  • The First Hospital of Lanzhou University Lanzhou, China
View Trial Details
Recruiting

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • The Regents of the University of California||UC Davis Health Rancho Cordova, California, United States
  • UC Davis Health Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
View all 23 locations
View Trial Details
Recruiting

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

NCT05936580

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UT Health San Antonio San Antonio, Texas, United States
  • Helsinki University Hospital,Coagulation Disorder Unit Helsinki, Finland
  • Avenue de la République Chambray-lès-Tours, France
  • CHU de Nantes Hôtel-Dieu Nantes, France
View all 16 locations
View Trial Details
Recruiting

ATHNdataset Registry

NCT06820515

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +33 more
Locations
  • American Thrombosis and Hemostasis Network Hickory, North Carolina, United States
View Trial Details

Related conditions